178 related articles for article (PubMed ID: 19626803)
21. Effects of raloxifene and alendronate on bone turnover as assessed by procollagen type I N-terminal propeptide.
Eastell R; Rogers A; Ni X; Krege JH
Osteoporos Int; 2011 Jun; 22(6):1927-34. PubMed ID: 20838771
[TBL] [Abstract][Full Text] [Related]
22. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
[TBL] [Abstract][Full Text] [Related]
23. The bone turnover markers in healthy Thai adults as the standard values.
Bunyaratavej N
J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S47-9. PubMed ID: 22338926
[TBL] [Abstract][Full Text] [Related]
24. Short-term response of bone turnover to low-dose oral contraceptives in exercising women with hypothalamic amenorrhea.
Vescovi JD; VanHeest JL; De Souza MJ
Contraception; 2008 Feb; 77(2):97-104. PubMed ID: 18226672
[TBL] [Abstract][Full Text] [Related]
25. The association of dietary calcium, bone mineral density and biochemical bone turnover markers in rural Thai women.
Pongchaiyakul C; Kosulwat V; Charoenkiatkul S; Chailurkit LO; Rojroongwasinkul N; Rajatanavin R
J Med Assoc Thai; 2008 Mar; 91(3):295-302. PubMed ID: 18575280
[TBL] [Abstract][Full Text] [Related]
26. Study of procollagen type1 nitrogenous propeptides (P1NP) in reproductive female.
Bunyaratavej N; Kittimanon N
J Med Assoc Thai; 2005 Oct; 88 Suppl 5():S27-8. PubMed ID: 16871656
[TBL] [Abstract][Full Text] [Related]
27. Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma.
Klepzig M; Jonas D; Oremek GM
Anticancer Res; 2009 Feb; 29(2):671-3. PubMed ID: 19331219
[TBL] [Abstract][Full Text] [Related]
28. Age-related reference intervals for bone turnover markers from an Australian reference population.
Jenkins N; Black M; Paul E; Pasco JA; Kotowicz MA; Schneider HG
Bone; 2013 Aug; 55(2):271-6. PubMed ID: 23603243
[TBL] [Abstract][Full Text] [Related]
29. Bone metabolism markers and ghrelin in boys at different stages of sexual maturity.
Jürimäe J; Pomerants T; Tillmann V; Jürimäe T
Acta Paediatr; 2009 May; 98(5):892-6. PubMed ID: 19243352
[TBL] [Abstract][Full Text] [Related]
30. Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation.
Tziakas DN; Chalikias GK; Papanas N; Stakos DA; Chatzikyriakou SV; Maltezos E
Europace; 2007 Aug; 9(8):589-96. PubMed ID: 17485436
[TBL] [Abstract][Full Text] [Related]
31. [N-terminal propeptide of type I procollagen (PINP)].
Sone T; Fukunaga M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():232-5. PubMed ID: 15658307
[No Abstract] [Full Text] [Related]
32. Development of a highly sensitive, high-throughput, mass spectrometry-based assay for rat procollagen type-I N-terminal propeptide (PINP) to measure bone formation activity.
Han B; Copeland M; Geiser AG; Hale LV; Harvey A; Ma YL; Powers CS; Sato M; You J; Hale JE
J Proteome Res; 2007 Nov; 6(11):4218-29. PubMed ID: 17924680
[TBL] [Abstract][Full Text] [Related]
33. Correlation between the circulating bone markers and vitamin D in the healthy Thai people.
Buranasinsup S; Jangsangthong A; Bunyaratavej N
J Med Assoc Thai; 2011 Oct; 94 Suppl 5():S90-5. PubMed ID: 22338936
[TBL] [Abstract][Full Text] [Related]
34. Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition.
Shieh A; Karlamangla AS; Gossiel F; Eastell R; Greendale GA
J Clin Endocrinol Metab; 2024 May; 109(6):1580-1589. PubMed ID: 38087944
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of simultaneous measurement of bone formation and bone resorption markers to assess bone turnover rate in postmenopausal women: an EPOLOS study.
Łukaszkiewicz J; Karczmarewicz E; Płudowski P; Jaworski M; Czerwiński E; Lewiński A; Marcinowska-Suchowierska E; Milewicz A; Spaczyński M; Lorenc RS;
Med Sci Monit; 2008 Dec; 14(12):PH65-70. PubMed ID: 19043376
[TBL] [Abstract][Full Text] [Related]
36. Safety of daily teriparatide treatment: a post hoc analysis of a Phase III study to investigate the possible association of teriparatide treatment with calcium homeostasis in patients with serum procollagen type I N-terminal propeptide elevation.
Yamamoto T; Tsujimoto M; Sowa H
Clin Interv Aging; 2015; 10():1101-9. PubMed ID: 26185429
[TBL] [Abstract][Full Text] [Related]
37. The parathyroid hormone level in Thai women.
Soontrapa S; Soontrapa S; Bunyaratavej N
J Med Assoc Thai; 2001 Oct; 84 Suppl 2():S566-9. PubMed ID: 11853282
[TBL] [Abstract][Full Text] [Related]
38. Critical differences in the serial measurement of three biochemical markers of bone turnover in the sera of pre- and postmenopausal women.
Scariano JK; Garry PJ; Montoya GD; Wilson JM; Baumgartner RN
Clin Biochem; 2001 Nov; 34(8):639-44. PubMed ID: 11849624
[TBL] [Abstract][Full Text] [Related]
39. Carbohydrate-deficient transferrin in relation to the menopausal status of women.
Leusink GL; Smeets-Goevaers CG; Breed SA; Keyzer JJ; van Pelt J
Alcohol Clin Exp Res; 2000 Feb; 24(2):172-5. PubMed ID: 10698368
[TBL] [Abstract][Full Text] [Related]
40. A multicenter study to evaluate harmonization of assays for N-terminal propeptide of type I procollagen (PINP): a report from the IFCC-IOF Joint Committee for Bone Metabolism.
Cavalier E; Eastell R; Rye Jørgensen N; Makris K; Tournis S; Vasikaran S; Kanis JA; Cooper C; Pottel H; Morris HA;
Clin Chem Lab Med; 2019 Sep; 57(10):1546-1555. PubMed ID: 31085740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
